Hospital
Bronson Lakeview Hospital
Bronson Lakeview Hospital was paid $15.63M by Medicaid between Jan 2018 and Dec 2024, across 219 billing codes. Its largest line is 99283, emergency room visit (moderate) — 21% of everything it billed.
33Billing provider infoBRONSON LAKEVIEW HOSPITAL
PAW PAW, MI 49079
PAW PAW, MI 49079
33aNPI1962508259assigned 09/15/2006
33bProvider typeMedicare Defined Swing Bed Hospital Unit
28Total paid$15.63M
24GClaims507,162
24DCodes billed219
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Medicare Defined Swing Bed Hospital Unit providers in Michigan
Rank by total paid#1 of 8
Median peer was paid$5.78M
This provider vs. median2.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official EAST, REBECCA controls 14+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 59,004 | $1.35M | |
| 2019 | 56,968 | $1.22M | |
| 2020 | 60,747 | $1.77M | |
| 2021 | 83,721 | $2.56M | |
| 2022 | 80,890 | $2.66M | |
| 2023 | 89,915 | $3.29M | |
| 2024incomplete | 75,917 | $2.77M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 21% | 22,664 | 21,508 | $3.29M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 15% | 10,700 | 10,052 | $2.38M |
| 41899 | Unlisted procedure, dentoalveolar structures | 7.2% | 1,166 | 1,165 | $1.13M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 6.2% | 10,063 | 9,775 | $972K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.5% | 2,755 | 2,661 | $862K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 5.1% | 8,501 | 7,889 | $793K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.3% | 2,924 | 2,884 | $512K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 3.3% | 15,029 | 5,020 | $511K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.8% | 6,794 | 6,593 | $430K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1.9% | 3,629 | 3,583 | $290K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.6% | 7,418 | 6,621 | $249K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.3% | 6,364 | 5,794 | $205K |
207 more codes
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 1.3% | 445 | $204K |
| 71046 | Radiologic examination, chest; 2 views | 1.1% | 4,609 | $176K |
| 71045 | Radiologic examination, chest; single view | 1.1% | 4,280 | $175K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 1,791 | $130K |
| 80061 | Lipid panel | <1% | 11,992 | $130K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,233 | $124K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 13,135 | $120K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 1,763 | $118K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 1,576 | $113K |
| 76830 | Ultrasound, transvaginal | <1% | 1,591 | $110K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,171 | $109K |
| G0378 | Hospital observation service, per hour | <1% | 352 | $108K |
| 80053 | Comprehensive metabolic panel | <1% | 28,735 | $107K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 1,670 | $100K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 5,638 | $98K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 1,361 | $93K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 731 | $83K |
| 36415 | Collection of venous blood by venipuncture | <1% | 42,511 | $83K |
| 97162 | <1% | 1,426 | $79K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 3,965 | $79K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 4,081 | $70K |
| 94060 | <1% | 360 | $70K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 3,913 | $68K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 3,913 | $68K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 31,418 | $67K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 9,765 | $58K |
| 86900 | <1% | 1,137 | $56K | |
| 72100 | <1% | 1,205 | $53K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 3,373 | $50K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 8,026 | $50K |
| 70310 | <1% | 782 | $49K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 378 | $43K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 130 | $42K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 512 | $42K |
| 74018 | <1% | 1,536 | $42K | |
| 76801 | <1% | 501 | $41K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,426 | $37K |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | <1% | 1,967 | $36K |
| 73562 | <1% | 1,509 | $35K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 1,352 | $32K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 2,499 | $30K |
| 97161 | <1% | 460 | $27K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 3,067 | $27K |
| 73030 | <1% | 1,095 | $22K | |
| 85027 | <1% | 5,552 | $21K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,039 | $20K |
| 73630 | <1% | 1,505 | $20K | |
| 82728 | <1% | 2,242 | $18K | |
| 93975 | <1% | 135 | $18K | |
| 84466 | <1% | 2,277 | $18K | |
| 73610 | <1% | 1,309 | $16K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 7,990 | $16K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 591 | $15K |
| 82607 | <1% | 1,781 | $15K | |
| 73130 | <1% | 1,108 | $15K | |
| 76770 | <1% | 202 | $15K | |
| 86780 | <1% | 1,503 | $14K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 53 | $14K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 465 | $13K |
| 86803 | <1% | 1,844 | $13K | |
| 84439 | <1% | 2,421 | $13K | |
| 84702 | <1% | 1,859 | $12K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 5,458 | $12K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 4,964 | $12K |
| 73502 | <1% | 429 | $11K | |
| 83540 | <1% | 2,383 | $9K | |
| 81025 | <1% | 6,212 | $9K | |
| 82043 | <1% | 2,082 | $8K | |
| 82570 | <1% | 2,294 | $7K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,070 | $7K |
| 94726 | <1% | 356 | $7K | |
| 87077 | <1% | 2,447 | $7K | |
| 87081 | <1% | 1,607 | $7K | |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 221 | $7K |
| 87631 | <1% | 553 | $7K | |
| 73110 | <1% | 496 | $7K | |
| 87186 | <1% | 2,081 | $6K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 802 | $6K |
| 86140 | <1% | 2,761 | $6K | |
| 83880 | <1% | 862 | $5K | |
| T1015 | A visit at a community health center or clinic (one all-in rate) | <1% | 110 | $5K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 28 | $5K |
| 81001 | <1% | 12,647 | $5K | |
| 81003 | <1% | 5,647 | $5K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 288 | $5K |
| 0011A | <1% | 135 | $5K | |
| 83735 | <1% | 2,482 | $4K | |
| 85610 | <1% | 2,681 | $4K | |
| 76536 | <1% | 64 | $4K | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 297 | $4K |
| 0012A | <1% | 108 | $4K | |
| 80076 | <1% | 962 | $4K | |
| 87340 | <1% | 1,107 | $4K | |
| 84484 | <1% | 4,710 | $3K | |
| 86038 | <1% | 518 | $3K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 79 | $3K |
| 85652 | <1% | 2,412 | $3K | |
| 93225 | <1% | 36 | $3K | |
| 86376 | <1% | 343 | $3K | |
| 83690 | <1% | 5,495 | $2K | |
| 72141 | <1% | 12 | $2K | |
| 93017 | <1% | 43 | $2K | |
| 77080 | <1% | 25 | $2K | |
| 0001A | <1% | 51 | $2K | |
| 97163 | <1% | 28 | $2K | |
| 0002A | <1% | 46 | $2K | |
| 82950 | <1% | 457 | $2K | |
| 83516 | <1% | 205 | $2K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 922 | $1K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,765 | $1K |
| 82565 | <1% | 387 | $1K | |
| 82746 | <1% | 152 | $1K | |
| 87070 | <1% | 306 | $1K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 12 | $1K |
| 84146 | <1% | 79 | $1K | |
| 73140 | <1% | 110 | $922.02 | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 81 | $903.97 |
| 76882 | <1% | 13 | $879.50 | |
| 73560 | <1% | 49 | $875.04 | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 32 | $848.11 |
| 10060 | <1% | 13 | $816.96 | |
| 85730 | <1% | 998 | $773.49 | |
| 83525 | <1% | 96 | $734.01 | |
| 97167 | <1% | 12 | $673.67 | |
| 86580 | <1% | 34 | $628.50 | |
| L4350 | Ankle control orthosis, stirrup style, rigid, includes any type interface (e.g., pneumatic, gel), prefabricated, off-the-shelf | <1% | 17 | $613.34 |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 26 | $599.95 |
| 76642 | <1% | 12 | $595.91 | |
| 86200 | <1% | 97 | $587.22 | |
| 90686 | <1% | 29 | $571.99 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 22 | $551.85 |
| 70486 | <1% | 13 | $468.94 | |
| 83013 | <1% | 12 | $437.91 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 130 | $427.89 |
| 87220 | <1% | 588 | $389.84 | |
| 84100 | <1% | 175 | $377.56 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 2,120 | $323.53 |
| 80305 | <1% | 138 | $311.25 | |
| 85380 | <1% | 821 | $285.95 | |
| 80074 | <1% | 14 | $268.40 | |
| 83605 | <1% | 2,875 | $249.53 | |
| 96376 | <1% | 1,611 | $243.66 | |
| 71101 | <1% | 12 | $241.77 | |
| 87040 | <1% | 963 | $210.11 | |
| Q9969 | Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose | <1% | 26 | $195.86 |
| 84403 | <1% | 12 | $194.60 | |
| 84145 | <1% | 349 | $189.46 | |
| 87205 | <1% | 73 | $180.85 | |
| 76870 | <1% | 13 | $156.15 | |
| 83001 | <1% | 12 | $154.11 | |
| 84481 | <1% | 12 | $153.24 | |
| 84703 | <1% | 429 | $130.73 | |
| 84550 | <1% | 64 | $130.15 | |
| 85018 | <1% | 107 | $126.41 | |
| 84153 | <1% | 12 | $119.79 | |
| 86901 | <1% | 1,173 | $100.18 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 7,462 | $89.82 |
| 82550 | <1% | 70 | $71.19 | |
| 86850 | <1% | 900 | $67.25 | |
| 80143 | <1% | 406 | $60.65 | |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | <1% | 86 | $58.94 |
| 94729 | <1% | 370 | $56.21 | |
| 83014 | <1% | 12 | $51.12 | |
| 80179 | <1% | 395 | $50.45 | |
| 82150 | <1% | 13 | $49.73 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,843 | $43.67 |
| 84460 | <1% | 13 | $32.33 | |
| 84450 | <1% | 13 | $31.64 | |
| 81002 | <1% | 14 | $25.26 | |
| 12001 | <1% | 98 | $25.03 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 8,341 | $21.77 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 4,801 | $12.98 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 8,000 | $12.65 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 6,542 | $12.33 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 159 | $11.91 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,738 | $9.44 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,546 | $8.57 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,431 | $5.76 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 520 | $3.23 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 798 | $1.99 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 3,358 | $0.51 |
| J2704 | Injection, propofol, 10 mg | <1% | 6,092 | $0.34 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 992 | $0.29 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 0% | 16 | $0.00 |
| 90715 | 0% | 574 | $0.00 | |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 0% | 109 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 211 | $0.00 |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | 0% | 618 | $0.00 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 0% | 186 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 49 | $0.00 |
| J2004 | Injection, lidocaine hcl with epinephrine, 1 mg | 0% | 39 | $0.00 |
| L3908 | Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf | 0% | 12 | $0.00 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 0% | 18 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 49 | $0.00 |
| 90472 | Immunization administration, each additional vaccine (list separately) | 0% | 17 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 1,215 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 3,281 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 1,067 | $0.00 |
| J1630 | Injection, haloperidol, up to 5 mg | 0% | 97 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 96 | $0.00 |
| A9270 | Non-covered item or service | 0% | 562 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 318 | $0.00 |
| 99214 | Doctor's office visit, returning patient (more involved) | 0% | 23 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 147 | $0.00 |
| 73090 | 0% | 12 | $0.00 | |
| J3490 | Unclassified drugs | 0% | 12 | $0.00 |
| 99213 | Doctor's office visit, returning patient (routine) | 0% | 46 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialEAST, REBECCA (SVP, CFO)
| Provider | Location | Paid |
|---|---|---|
| Bronson Methodist Hospital | Kalamazoo, MI | $109.07M |
| Bronson Methodist Hospital | Kalamazoo, MI | $64.91M |
| Bronson Battle Creek Hospital | Battle Creek, MI | $43.89M |
| Bronson South Haven Hospital | South Haven, MI | $10.85M |
| Bronson Battle Creek Hospital | Battle Creek, MI | $9.80M |
| Bronson Lakeview Hospital | Paw Paw, MI | $6.57M |
| Bronson South Haven Hospital | South Haven, MI | $3.92M |
| Bronson at Home | Battle Creek, MI | $2.96M |
| Bronson Methodist Hospital | Kalamazoo, MI | $1.93M |
| Bronson South Haven Hospital | South Haven, MI | $704K |
| Bronson Lakeview Hospital | Decatur, MI | $563K |
| Bronson Lakeview Hospital | Bangor, MI | $530K |
| Bronson Lakeview Hospital | South Haven, MI | $134K |
| Bronson Lakeview Hospital | Paw Paw, MI | $2K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.